Köhler, Stefanie http://orcid.org/0000-0002-7417-333X
Görß, Doreen http://orcid.org/0000-0002-5336-8349
Kowe, Antonia http://orcid.org/0000-0001-5684-5609
Teipel, Stefan J. http://orcid.org/0000-0002-3586-3194
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01GP1901C)
European Union (TBI-1-103-VBW-035)
European Union (ESF/14-BM-A55-0021/19)
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft
Article History
Accepted: 22 June 2022
First Online: 12 July 2022
Declarations
:
: Stefanie Köhler is a lecturer at the Europäischen Fachhochschule Rostock, Germany and for the German Alzheimer’s Association, regional group Mecklenburg-Western Pomerania. Antonia Kowe is fellow of the program “Freies Wissen” by Wikimedia Deutschland. Doreen Görß declares to have no conflict of interest. Stefan Teipel has done the listed works below (all in Germany): MSD Sharp & Dohme GmbH, Lindenplatz 1, 85540 Haar: 11/09/2018—Quality circle for physicians in Kühlungsborn, Talk: “Dementia and Diabetes—current report”; 14/11/2018—MSD Expert-forum: NAB Alzheimer in Munich, participator as consultant & 13/08/2019—Event “Diabetes and Dementia” in Rostock, Talk: “Dementia and Diabetes—current report.” ROCHE Pharma AG, Emil-Barell-Str. 1, 79639 Grenzach-Wyhlen: 12/09/2019—3. Nationales Advisory-Board in Frankfurt am Main, participator as consultant & 27/09/2019—ROCHE Symposium at the DGN Congress in Stuttgart, Talk: “Amyloid as target for diagnosis and treatment in Alzheimer´s disease”. Biogen GmbH, Riedenburger Straße 7, 81677 München: 23/04/2020—Biogen Advisory Board Session.
: The study was approved by the responsible ethics committee of the University Medical Center Rostock (A 2018–0109) and conducted in accordance with the Declaration of Helsinki (WMA, CitationRef removed). All participants or their legal representatives provided written informed consent. Interviewers ensured ongoing consent during questioning.